Carter Julian Ward - 19 Jan 2022 Form 4 Insider Report for Enveric Biosciences, Inc. (ENVB)

Reporting relationship: Chief Financial Officer
Issuer ticker: ENVB
Reported as of: 19 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Jan 2022, 15:57:13 UTC
Prior SEC filing: 27 May 2021
Source filing: View source filing
Reporting owner signature: /s/ Carter Julian Ward

Key filing fact

Carter Julian Ward filed Form 4 for Enveric Biosciences, Inc. (ENVB) on 25 Jan 2022.

Key facts

This page summarizes Carter Julian Ward's Form 4 filing for Enveric Biosciences, Inc. (ENVB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 25 Jan 2022, 15:57.

Change

Previous filing in this sequence was filed on 27 May 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENVB transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +744,429
Change %
Price: $0.000000
Shares after: 744,429
Date: 19 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 744,429
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the restricted stock units (the "RSUs") granted to the reporting person pursuant to the Enveric Biosciences, Inc. (the "Company") 2020 Long-Term Incentive Plan. For each vested restricted stock unit, the reporting person will be entitled to receive one share of common stock.

Footnote F2

50% of the RSUs shall vest over 4 years in equal annual installments, with the first tranche to vest on January 19, 2023. 50% of the RSUs shall vest in 3 approximately equal tranches on each of December 31, 2022, 2023 and 2024, if the Company's average VWAP (calculated as the average over the fourth calendar quarter of each of 2022, 2023 and 2024, as applicable, of the daily volume weighted average price of a share of common stock), exceeds $1.72, $1.89, $2.08, respectively.